HER2 Support Group Forums - View Single Post - head of breast oncology @ UCLA reviews promising new agents vs. her2+ breast cancer

Rolepaul · 07-13-2012, 05:48 AM

I thought they were seeing side effects at an unacceptable level in the PI3K/mTOR inhibitors trial. Also this is a novel production method. I hope I am mistaken in both cases.

07-13-2012, 05:48 AM	#4
Rolepaul Senior Member Join Date: Jan 2012 Location: Boulder Colorado as of January 2013 Posts: 391	Re: head of breast oncology @ UCLA reviews promising new agents vs. her2+ breast canc I thought they were seeing side effects at an unacceptable level in the PI3K/mTOR inhibitors trial. Also this is a novel production method. I hope I am mistaken in both cases.